Please login to the form below

Not currently logged in
Email:
Password:

AZ files Crestor patent lawsuits in US

AstraZeneca files patent infringement lawsuits against seven pharmaceutical companies that are attempting to market generic versions of its cholesterol-lowering blockbuster Crestor

UK-based pharmaceutical company, AstraZeneca (AZ), has filed patent infringement lawsuits against seven pharmaceutical companies that are attempting to market generic versions of its cholesterol blockbuster Crestor (rosuvastatin).

The lawsuits were filed in US District Court against the US-based companies Cobalt, Aurobindo Pharma, Par Pharmaceutical, Mylan Pharmaceuticals and Sun Pharmaceutical. Canada's Apotex and Germany's Sandoz International are also involved.

Crestor is AZ's third-best-selling treatment, with FY06 sales of USD 2bn. Shares in the company dropped in value by 0.9 per cent to reach GBP 22.77 (USD 46.58) in midday trading on 12 December 2007 in London.

12th December 2007

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Just::Health Communications

Just:: is a different kind of healthcare communications agency. Since 2006, we’ve been collaborating with clients around the world to...

Latest intelligence

Finding the patient voice
How patients feel and speak about clinical trials...
Six Factors to Consider When Designing Advisory Boards
...
The good, the bad and the ugly
Tracking the pharmaceutical industry’s 2017 evolution and assessing how things may shape up in 2018 - it’s a trilogy of trends...

Infographics